Astellas Pharma Inc 2013 AR2
The report details Astellas Pharma Inc.'s business performance and sustainability initiatives for the fiscal year ended March 31, 2013. Key highlights include the successful global launch of new growth drivers, such as XTANDI for prostate cancer and Myrbetriq/BETMIGA for overactive bladder. The company integrated its Annual Report with its CSR report to present a comprehensive view of its economic, social, and environmental activities. Astellas also advanced its 'Access to Health' initiatives by engaging in collaborative research for neglected tropical diseases and developing a pediatric formulation for schistosomiasis. On the environmental front, the company achieved its 2015 water reduction target ahead of schedule and maintained zero waste emissions in Japan.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2013
Type: AR2
Pages: 142
Back to company
Astellas Pharma Inc
Annual Report
The report details Astellas Pharma Inc.'s business performance and sustainability initiatives for the fiscal year ended March 31, 2013. Key highlights include the successful global launch of new growth drivers, such as XTANDI for prostate cancer and Myrbetriq/BETMIGA for overactive bladder. The company integrated its Annual Report with its CSR report to present a comprehensive view of its economic, social, and environmental activities. Astellas also advanced its 'Access to Health' initiatives by engaging in collaborative research for neglected tropical diseases and developing a pediatric formulation for schistosomiasis. On the environmental front, the company achieved its 2015 water reduction target ahead of schedule and maintained zero waste emissions in Japan.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Apr 1, 2012 - Mar 31, 2013
Fiscal Year
2012
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women in Management
Employees